Hello, Fool! | Login | Signup | My Fool
Jul 18, 2008 1:35 PM ET | Site Changes | Help
Search: Tickers Company Names Players
The Company is a specialty pharmaceutical company focused on the prevention and treatment of oral cancer.
View All Commentary (ZILA)
Recs
dkoolguy7000 (< 20) Submitted: 9/27/06 10:20 AM : Start Price: $2.23 ZILA Score: -81.96
Zila has been hit hard the last month with speculation that the management is corrupt only looking to put money in their pockets by selling off the only unit of the business that currently brings in the revenue. However, I am still optimistic that the approval of OraTest will happen in the near future propelling the stock to highs never seen before.
Report this Post Replies: 2 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
1poorguy (97.92) Submitted: 9/29/06 4:12 PM
Recs: 1 | Rec This
They've been promising that for years. I owned this one several years ago, and when they submitted to the FDA it was rejected because the data was not gathered properly. How can a pharm company NOT gather data in accordance with FDA regs?? It's not like those regs are secret. Simple incompetence at Zila. I'm fortunate my stop order got me out before the bottom fell out.
Report this Post Reply
30sbaby (< 20) Submitted: 7/02/07 8:21 PM
Recs: 0 | Rec This
I hoped you're right. I've owned this baby since about 1988 and have been waiting for OraTest to be FDA approved for, it seems like, forever. If I'm not mistaken, Zila hit a high of about $12 in early January several years ago. I was on vacation and missed the opportunity to sell at a very good profit. Luckily I'm patient.